bioRxivCancer BiologyPreprint
Preparation of cationized albumin nanoparticles loaded indirubin by high pressure hemogenizer
H. Nekounam, R. Dinarvand, R. Khademi, N. Mahmoodi, H. Arzani, E. Hasanzadeh, R. Karimi, M. Kamali, M. Khosravani
Abstract
Indirubin can be applied as an anti-cancer drug for inhibition of brain tumors. However, its performance is reduced due to hydrophobicity. In this study, we synthesized cationic human serum albumin (CHSA) nanoparticle by a new hybrid approach for improvement the surface chemistry of albumin and investigate the amount of indirubin loaded CHSA nanoparticle. In this study, the generated mechanical force from a high-pressure homogenizer (HPH) was used to make nanoparticles with a certain size with narrow polydispersity. The results indicated that the size of indirubin loaded CHSA nanoparticles were 130 nm and their zeta potential were +9. Besides, the encapsulation efficiency and drug loading capacity were found to be 85% and 5.8 %, respectively. To the best to our knowledge, this is the first time that indirubin has been used in albumin nanoparticles. In this study, indirubin loaded CHSA nanoparticles was shown can be a potential candidate for drug delivery in the treatment of glioblastoma. Moreover, the cationized form allows the chemical agent to be transmitted to the brain.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heparin-derived theranostic nanoprobes overcome the blood-brain barrier and target glioma in murine model
S. Samanta, V. Le Joncour, … O. P. Oommen·bioRxiv·Jan 7, 2022
- Effect of structure in ionized albumin - based nanoparticle: Characterisation, Emodin interaction, and in vitro cytotoxicity
M. Siri, M. J. F. Ruocco, … S. d. V. Alonso·bioRxiv·May 8, 2019
- Synthesis and Characterisation of a Macrophage-derived Hybrid Nanoparticles for Doxorubicin Delivery to Glioblastoma
Girstautė Dabkevičiūtė, Christian Celia, Vilma Petrikaitė·bioRxiv·May 22, 2026
- Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
H. Onafuye, S. Pieper, … M. Michaelis·bioRxiv·May 31, 2019
- A robust and versatile nanobody platform for drug delivery
- Systemic Brain Tumor Delivery of Synthetic Protein Nanoparticles for Glioblastoma Therapy
J. V. Gregory, P. Kadiyala, … J. Lahann·bioRxiv·Jan 9, 2020